Clinical Manifestations and Evaluation of Postmenopausal Vulvovaginal Atrophy


The ISSVD Vaginitis and Microbiome Committee Subcommittee on vaginal atrophy has published a manuscript titled Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy. It is estimated that 50% of women will suffer a severe form of vulvovaginal atrophy (VVA) related to menopause. Equally, young women may temporarily present this clinical problem while receiving various pharmacological or endocrine treatments or radiotherapy.

Faustino R. Pérez-López, Pedro Vieira-Baptista, Nancy Phillips, Bina Cohen-Sacher, Susana C. A.V. Fialho & Colleen K. Stockdale (2021): Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.Gynecological Endocrinology, DOI: 10.1080/09513590.2021.1943346


The International Society for the
Study of Vulvovaginal Disease (ISSVD)

Contact Us

PO Box 586
Waxhaw, NC 28173

Get free ISSVD updates

Delivered straight to your inbox.

Click Here

Copyright © 2017 - 2021 All Rights Reserved.
Made in Charlotte by Synchronicity
Reproduction and distribution of contents including images and artwork, in whole or in part, without prior written agreement is prohibited.